IBRX
IBRX · Mid Cap · Healthcare · Biotechnology
$8.13+$0.05 (+0.62%)
Free research brief
Get the full brief on IBRX
Free to track. No card required.
Where IBRX sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$1.95
High$12.43
Today $8.13
RSI (14)
54.2Neutral
03070100
Overall score
61/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Current price
$8.13
Lowest
$12
Median target
$12
Highest
$15
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Current ratio
Strong · Good liquidity position
5.72x
⚠ Things to watch
Price / sales
Rich · Overpriced by revenue
51.65x
ROIC
Weak · Weak capital efficiency
-69.1%
How it stacks up against its peers
IBRX against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $8.56B | - | +192.9% | 61 |
 | $10.51B | 20.0 | +19.7% | 78 |
 | $33.17B | 34.7 | +15.5% | 78 |
 | $4.12B | 12.4 | +13.5% | 78 |
 | $1.08T | 39.1 | +49.6% | 77 |